Among mRNA tech, vaccines have been the primary target of the federal government's ire, despite experts' warnings that ...

If mass vaccine deaths are imminent, it is not evident in the global life expectancy trends. Since the rollout of billions of ...

RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system ...

The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Even before its $250 million Hazelwood Green facility is finished in 2028, researchers are already making breakthroughs in biomanufacturing.

How deep will the anti-science MAHA invasion penetrate into Mississippi? Can beleaguered state health officer Dr. Daniel ...

In this week’s edition of The Prototype, we look at the man trying to build the next Tesla, a retinal implant that restores ...